Biotron (Western University)

Using genomics to reduce the carbon footprint of the agri-food industry

Retrieved on: 
星期三, 九月 6, 2023
Genome Canada, Genomics, Fertilizer, Fishery, Parafilm, Centrale, Fungus, Science, Forestry, Transport, INRS, David Suzuki Foundation, Waste management, Ivey Business School, Research, Government, Tricycle, Compost, McGill University, Local government in Canada, Université de Montréal, Bacteria, Treasury Board of Canada, Environment and Climate Change Canada, LOOP, DNA, Biotron (Western University), Climate change, Carbon, Montreal Botanical Garden, The Wilderness Society, Climate change mitigation, Environment, Greenhouse, Food, Western University, Agriculture, University, Park, City, Food chain, CO2, Farm, Cryptocurrency, Management, Landfill, Renewable energy, Municipality of the County of Inverness

With that in mind, new approaches are essential to reduce the carbon footprint of the country's agri-food sector.

Key Points: 
  • With that in mind, new approaches are essential to reduce the carbon footprint of the country's agri-food sector.
  • In other words, how are agri-food byproducts or food leftovers biodegraded by microorganisms, fungi or insects that feed on them?
  • Their expertise will help us reduce the carbon footprint of Canada's food production systems while continuing to develop innovation."
  • As a result of their work, the research teams will propose biotechnological innovations to reduce the carbon footprint of Canada's bio-food production systems.

Specific Biologics Closes Seed Financing with Industry Leaders Lumira Ventures and adMare BioInnovations

Retrieved on: 
星期四, 十二月 16, 2021
Organization, Western University, Schulich School of Medicine & Dentistry, Ecosystem, Genomics, Cell, Intelligence, Genome, Gene editing, Growth, Industry, Biotron (Western University), Medicine, Lists of diseases, Bachelor of Engineering, CEO, Research, Gene, Robotics, Patient, Therapy, St John's Innovation Centre, DNA, Efficiency, Multimedia, ADMAR, Partnership, Vaccine, Pharmaceutical industry, Medical device, Pregnancy specific biological substances, Investment, Specific

TORONTO, Dec. 16, 2021 /PRNewswire/ - Specific Biologics Inc. ("Specific") today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare BioInnovations which have recently established an innovative partnership to build Canadian life sciences companies.

Key Points: 
  • TORONTO, Dec. 16, 2021 /PRNewswire/ - Specific Biologics Inc. ("Specific") today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare BioInnovations which have recently established an innovative partnership to build Canadian life sciences companies.
  • "We are excited to work alongside adMare and the Specific team to grow the company and bring transformative therapies to patients."
  • "The investment in Specific Biologics stems from a new partnership between adMare and Lumira Ventures," commented Dr. Frdric Lematre Auger, Managing Partner, Investments with adMare.
  • Specific Biologics Inc. ("Specific") is a venture-backed early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through precision gene editing.